Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.45 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | PLAAT3 | P53816 | 1/20 | 0.43 |
| ▸ | PLAAT5 | Q96KN8 | 1/20 | 0.43 |
| ▸ | PLAAT2 | Q9NWW9 | 1/20 | 0.43 |
| ▸ | PLAAT4 | Q9UL19 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.43 |
| ▸ | CTSD | P07339 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6232315 | 1.00 | SMN1; SMN2 (0.52) | SMN1; SMN2ALDH1A1MTNR1AMTNR1BPOLB | |
| SCHEMBL6230786 | 0.94 | KMT2A (0.48) | SMN1; SMN2ALDH1A1MTNR1AMTNR1BMEN1 | |
| SCHEMBL6231553 | 0.94 | KMT2A (0.48) | SMN1; SMN2ALDH1A1MTNR1AMTNR1BMEN1 | |
| SCHEMBL6228949 | 0.90 | ALDH1A1 (0.45) | SMN1; SMN2ALDH1A1MTNR1AMTNR1BLMNA | |
| SCHEMBL6230872 | 0.90 | LMNA (0.53) | ALDH1A1POLBKMT2ALMNAPKM | |
| SCHEMBL6228605 | 0.90 | ALDH1A1 (0.45) | SMN1; SMN2ALDH1A1MTNR1AMTNR1BLMNA | |
| SCHEMBL6230875 | 0.90 | LMNA (0.53) | ALDH1A1POLBKMT2ALMNAPKM | |
| Mandipropamid SCHEMBL675075 | 0.89 | GAA (0.52) | SMN1; SMN2ALDH1A1MEN1KMT2ALMNA | |
| SCHEMBL6233243 | 0.89 | MAPT (0.48) | SMN1; SMN2ALDH1A1POLBLMNAMAPT | |
| SCHEMBL6232313 | 0.89 | KMT2A (0.48) | SMN1; SMN2ALDH1A1MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1444197-B1 | NOVEL PHENYL-PROPARGYLETHER DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2005-03-30 | — | — | EP | claimed |
| US-20050026785-A1 | Novel phenyl-propargylether derivatives | SYNGENTA CROP PROTECTION, INC. | 2005-02-03 | — | — | US | claimed |
| EP-1444197-B1 | NOVEL PHENYL-PROPARGYLETHER DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2005-03-30 | — | — | EP | disclosed |
| US-20050026785-A1 | Novel phenyl-propargylether derivatives | SYNGENTA CROP PROTECTION, INC. | 2005-02-03 | — | — | US | disclosed |
| EP-1444197-A1 | NOVEL PHENYL-PROPARGYLETHER DERIVATIVES | Syngenta Participations AG (CH) | 2004-08-11 | — | — | EP | disclosed |
| WO-2003041728-A9 | NOVEL PHENYL-PROPARGYLETHER DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2004-04-22 | — | — | WO | disclosed |
| WO-2003041728-A1 | NOVEL PHENYL-PROPARGYLETHER DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2003-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050026785-A1 | Novel phenyl-propargylether derivatives | OR10J3, PRXL2A, OSR1 | SMN1; SMN2 4752/4885ALDH1A1 1556/4885MTNR1A 1647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.